The global Bioreactors Market is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021. The increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics are spurring the growth of the bioreactors market. However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market.

The global bioreactor market is segmented on the basis of end-users, usage, scale, material, control types and suppliers. Furthermore, the geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=59253123

The North American region accounted for the largest share in the bioreactors market in 2016. One of the main factors contributing to this large share is the increase in number of biomanufacturing facilities and investments in this region. Government in North American countries actively supports the biologics production by providing funds to life science R&D.

The bioreactors market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of leading players in the market. Some of the leading players offering bioreactor products are Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher Corporation (U.S), Eppendorf AG (Germany).

Press Release: https://www.marketsandmarkets.com/PressReleases/bioreactor.asp